Clinical Trials in Houston

Showing 12281-12300 of 15,366 trials

Safety and Efficacy of EVT 101 in Treatment-Resistant Depression

NCT01128452

This study is a 4-week, randomized, double-blind, parallel-group, placebo-controlled monotherapy study in patients with treatment-resistant major depression. After confirmation of treatment-resistance in a prospective treatment period with citalopram, each patient will be treated with either EVT 101 once daily or placebo for 28 consecutive days.

Depression

Janssen Research & Development, LLC8 participantsStarted Jun 2010

Oceanside, California, United States • San Diego, California, United States • Tampa, Florida, United States +11 more locations

COMPLETEDPhase 4< 1 mile

Ambu® Laryngeal Mask as an Intubation Conduit

NCT00272194

The purpose of this study is to determine if the Ambu Laryngeal Mask can be used as an intubation conduit for endotracheal intubation.

Intubation, Endotracheal

The University of Texas Health Science Center, Houston160 participantsStarted Dec 2005

Houston, Texas, United States

COMPLETEDPhase 4< 1 mile

Dexmedetomidine vs. Remifentanil for Sedation During AFI

NCT00349245

The objective of this study is to determine the efficacy and safety of Dexmedetomidine, a selective alpha-2 adrenoceptor agonist, which has recently gained increased popularity for ICU and intraoperative sedation as a sedative during awake fiberoptic intubation, as compared to Remifentanil. The hypothesis is that Dexmedetomidine will provide at least equal if not better conditions (sedation and analgesia) required for awake fiberoptic intubation (Ramsay Sedation Scale 3) with less respiratory and cardiovascular adverse effects, as well as less recall than Remifentanil.

Intubation, Endotracheal

The University of Texas Health Science Center, Houston30 participantsStarted Jun 2006

Houston, Texas, United States

Safety and Efficacy of EVT 101 in Treatment-Resistant Depression

Ambu® Laryngeal Mask as an Intubation Conduit

Dexmedetomidine vs. Remifentanil for Sedation During AFI

Find Trials by Condition in Houston

Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer

Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation

Phase I/II Trial of RAD001 Plus Nexavar in Patients With Kidney Cancer

Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before Prostatectomy

Safety Study of TroVax Alone vs. TroVax Plus Interferon Alpha in Patients With Renal Cancer

Safety Study of RAD001 to Treat Patients With Metastatic Kidney Cancer

Activity of TroVax® Alone vs. TroVax® Plus GM-CSF in Patients With Prostate Cancer

Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.

Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms

Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration

A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation.

Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib

Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC)

Bioequivalence Study of IG-001 Versus Nab-paclitaxel in Metastatic or Locally Recurrent Breast Cancer

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Long-term, Safety and Tolerability Study of AFQ056 in Adolescent Patients With Fragile X Syndrome (Open-label)

Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs